Crescent Grove Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,312
| Closed | -$201K | – | 305 |
|
|
2023
Q1 | $201K | Sell |
1,312
-74
| -5% | -$11.4K | 0.02% | 272 |
|
|
2022
Q4 | $249K | Sell |
1,386
-500
| -27% | -$89.8K | 0.03% | 246 |
|
|
2022
Q3 | $223K | Buy |
1,886
+350
| +23% | +$41.4K | 0.03% | 237 |
|
|
2022
Q2 | $219K | Buy |
1,536
+150
| +11% | +$21.4K | 0.02% | 237 |
|
|
2022
Q1 | $239K | Buy |
+1,386
| New | +$239K | 0.02% | 259 |
|
|
2021
Q4 | – | Sell |
-902
| Closed | -$347K | – | 300 |
|
|
2021
Q3 | $347K | Buy |
902
+22
| +3% | +$8.46K | 0.04% | 190 |
|
|
2021
Q2 | $207K | Buy |
+880
| New | +$207K | 0.02% | 246 |
|